Captor Therapeutics ® Investor Relations

      Investor Relations

      Registration of the increase of the share capital through the issuance of G series shares

      Publication date: 2021-05-24
      Number: RB ESPI 8/2021

      Current report no. 8/2021

      Date of preparation: 24 May 2021
      Subject: Registration of the increase of the share capital through the issuance of G series shares
      Legal basis: § 5 point 1 of the Regulation of the Minister of Finance dated 29 March 2018 on current and periodical information disclosed by issuers of securities and conditions for recognition as equivalent of information required by the provisions of law of a country other than a member state


      The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the “Company”) informs that it became aware that on 24 May 2021 the District Court for Wrocław-Fabryczna in Wrocław, VI Commercial Division of the National Court Register, registered the increase of the share capital of the Company from PLN 325,647.20 to PLN 412,797.20, through the issuance of 871,500 series G ordinary bearer shares with a nominal value of PLN 0.10 each, on the basis of Resolution no. 11 of the Extraordinary General Meeting of the Company dated 8 January 2021.
      As of the date of publication of this report the total number of votes arising from all issued shares of the Company amounts to 5,275,365. The share capital of the Company consists of 4,127,972 shares with a nominal value of PLN 0.10 each, including:

      1. 799,750 series A registered shares, with privileged voting rights such that each series A share carries two votes at the General Meeting of the Company;
      2. 1,757,075 B series shares;
      3. 82,449 C series shares;
      4. 97,051 D series shares;
      5. 347,643 series E registered shares, with privileged voting rights such that each series E share carries two votes at the General Meeting;
      6. 26,925 F series shares;
      7. 871,500 G series shares;
      8. 52,354 H series shares;
      9. 9,082 I series shares; and
      10. 84,143 J series shares.

      The amended provisions of the Company’s Articles of Association in connection with the registered increased of the capital read as follows:
      Ҥ 6 sec. 1 The share capital of the Company amounts to PLN 412,797.20 (four hundred twelve thousand seven hundred ninety seven zlotys and 20/100) and is divided into 4,127,972 (four million one hundred twenty seven thousand nine hundred seventy two) shares with a nominal value of PLN 0.10 (ten groszy) each, including:
      1) 799,750 (seven hundred ninety nine thousand seven hundred fifty) series A registered preference shares;
      2) 1,757,075 (one million seven hundred fifty seven thousand seventy five) series B ordinary registered shares;
      3) 82,449 (eighty two thousand four hundred forty nine) series C ordinary registered shares;
      4) 97,051 (ninety seven thousand fifty one) series D ordinary registered shares;
      5) 347,643 (three hundred forty seven thousand six hundred forty three) series E registered preference shares;
      6) 26,925 (twenty six thousand nine hundred twenty five) series F ordinary registered shares;
      7) 871,500 (eight hundred seventy one thousand five hundred) series G ordinary bearer shares;
      8) 52,354 (fifty two thousand three hundred fifty four) series H ordinary registered shares;
      9) 9,082 (nine thousand eighty two) series I ordinary registered shares; and
      10) 84,143 (eighty four thousand one hundred forty three) series J ordinary registered shares.”